Yüklüyor......
Pharmacologic Control of CAR T Cells
Chimeric antigen receptor (CAR) therapy is a promising modality for the treatment of advanced cancers that are otherwise incurable. During the last decade, different centers worldwide have tested the anti-CD19 CAR T cells and shown clinical benefits in the treatment of B cell tumors. However, despit...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8122276/ https://ncbi.nlm.nih.gov/pubmed/33919245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22094320 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|